From: Early onset of treatment effects with oral risperidone
Number of participants: | 48 (25 males/23 females) |
Age: | 36.9 ± 13.4 years (range 18 – 68 years) |
PANSS at admission: | 110.9 ± 20.4 (range 72 – 158) |
CGI at admission: | 5.9 ± 0.6 (range 5 – 7) |
Duration of treatment: | 13.4 ± 9.7 days (range 1 – 31 days) |
Maximum dose of risperidone: | 6.1 ± 1.4 mg/d (range 4 – 8 mg/d) |